Green Thumb Industries (GTBIF) Operating Margin (2019 - 2026)
Green Thumb Industries (GTBIF) posted Operating Margin of 13.57% for Q1 2026, up 121.69% on a QoQ basis from 6.12% in Q4 2025, and down 163.0% year-over-year from 21.54% in Q1 2025.
Green Thumb Industries (GTBIF) Operating Margin (2019 - 2026) Analysis & Trends
Green Thumb Industries' Operating Margin history runs 8 years deep, the most recent figure standing at 13.57% for Q1 2026.
- Quarterly Operating Margin fell 163.0% year-over-year to 13.57% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 11.37% (down 583.0% YoY) and the FY2025 annual result came in at 11.72%, down 802.0% from the prior year.
- Operating Margin was 13.57% for Q1 2026 at Green Thumb Industries, up from 6.12% in the prior quarter.
- Across five years, Operating Margin topped out at 25.62% in Q1 2024 and bottomed at 17.17% in Q4 2022.
- A 5-year average of 15.21% and a median of 17.78% in 2023 frame the typical range for Operating Margin.
- Annual changes were most pronounced in 2022 — Operating Margin sank 3950 bps — and 2023, when it surged 3526 bps.
- Green Thumb Industries' Operating Margin stood at 17.17% in 2022, then surged by 205 bps to 18.09% in 2023, then advanced by 7 bps to 19.4% in 2024, then sank by 68 bps to 6.12% in 2025, then soared by 122 bps to 13.57% in 2026.
- Business Quant data shows GTBIF's Operating Margin at 13.57% in Q1 2026, 6.12% in Q4 2025, and 12.61% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | 13.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.57% |
| Dec 31, 2025 | 6.12% |
| Sep 30, 2025 | 12.61% |
| Jun 30, 2025 | 13.45% |
| Mar 31, 2025 | 15.20% |
| Dec 31, 2024 | 19.40% |
| Sep 30, 2024 | 14.86% |
| Jun 30, 2024 | 19.28% |
| Mar 31, 2024 | 25.62% |
| Dec 31, 2023 | 18.09% |
| Sep 30, 2023 | 17.80% |
| Jun 30, 2023 | 16.27% |
| Mar 31, 2023 | 17.78% |
| Dec 31, 2022 | -17.17% |
| Sep 30, 2022 | 18.67% |
| Jun 30, 2022 | 24.48% |
| Mar 31, 2022 | 22.49% |
| Dec 31, 2021 | 22.33% |
| Sep 30, 2021 | 24.85% |
| Jun 30, 2021 | 22.92% |